James Holmes and the Batman Shooting: Is Big Pharma Responsible For This Massacre

One thing the corporate run media has yet to mention is the probable prescription drug connection to this shooting rampage in that Aurora movie theater. The have remained mute. Anderson Cooper vowed not to even mention his name while Pierce Morgan decided to have a debate about gun control before the the bodies were even cold.

For years Doctor Peter Breggin has been warning the FDA and Congress to the dangers of these prescription poisons.

This is no conspiracy theory folks. Doctor Bregging is presenting the cold hard facts and science. Please watch the videos and pass them on.

The conspiracy theorists are claiming this was staged. That's a remote possibility but the more logical explanation is the same as for all the school shooting and other murders ... Prescription drugs. Even in the Casey Anthony case there were prescription drugs involved and in all the accounts of people who knew her she also underwent a drastic personality change. IMO this was not more staged that the many school shootings. Holmes planned this all by himself. Holmes has a very high IQ. The guns were easily obtainable as was the ammo. Bullet resistant body armor is available online.



The TV shrinks will be running their mouths and presenting theory as fact. Dr Drew will pipe in with his usual bullshit but don't expect him to implicate prescription drugs since Holmes was not an addict. Dr Phil will pontificate as well in order to exploit this for ratings and he will in all likelihood be talking about the victims so his brain dead audience can have their warm fuzzies but you will not hear any mention of  the mind altering effects of prescription drugs being catalyst in the shootings even though it is widely known that all the school shooting involved prescription antidepressant medications.


Alex Jones in his usual paranoid delusion is presenting one of his nut job conspiracy theories. If you want good laugh check out Alex Jones Says Batman Shooting Staged

There is no conspiracy here. Prescription drugs like the SSRIs SNRIs were the culprits in the school shootings and many other shooting rampages. Drugs like Prozac, Paxil, Wellbutrin, Lexapro, Cipralex, Celexa, Zoloft, Lustra, Pristiq, Cymbalta, were involved in all the school shootings.




It may not come out that Holmes was on a an anti depressant until the trial. The mainstream media will talk about gun control, half baked psychological theories and exploit the victims for ratings but don't expect to hear any discussion about the role drugs may have played  in the shooting, wounding and deaths of the Aurora movie theater shooting victims.




It's too bad that these shooters always end up killing innocent people. When there are so many scumbags who need killing like the 1%.

Traction and Disk Heriations

American Spine Surgeons are the worst in the industrialized world as well as highest paid and greediest. That may be why most of them don't recommend traction for disk hernias. 

The following study was conducted in Korea so chances are it is more reliable and honest than anything you will find in the greedy US.

 

Reducibility of Cervical Disk Herniation: Evaluation at MR Imaging during Cervical Traction with a Nonmagnetic Traction Device

1. Tae-Sub Chung, MD,
2. Young-Jun Lee, MD,
3. Seong-Woong Kang, MD,
4. Chang-Jun Park, MD,
5. Won-Suk Kang, MSc and
6. Yong-Woon Shim, MD

1. ¹From the Department of Diagnostic Radiology and Research Institute of Radiological Science, Brain Korea 21 Project for Medical Science (T.S.C., Y.J.L., W.S.K., Y.W.S.), and Department of Rehabilitation Medicine (S.W.K.), Yonsei University College of Medicine, YongDong Severance Hospital, 146-92 Dogok-Dong, Kangnam-Gu, Seoul 135-270, Korea; and Airtrac MSI, Seoul, Korea (C.J.P.). From the 2000 RSNA scientific assembly. Received July 17, 2001; revision requested September 17; final revision received March 25, 2002; accepted May 14. Supported by Airtrac grant 1999-31A1-00014. Address correspondence to T.S.C. (e-mail: tschung@yumc.yonsei.ac.kr).

Next Section

Abstract

The authors evaluated the reducibility of cervical disk herniation at magnetic resonance (MR) imaging performed with the patient in cervical traction. After the acquisition of neutral-state images, cervical traction images were obtained in 29 patients and seven healthy volunteers while they wore a portable intermittent traction device. During traction, all volunteers and 21 patients had a substantial increase in the length of the cervical vertebral column. The disk herniation was completely resolved in three patients and partially reduced in 18. The reducibility of cervical disk herniation can be evaluated at MR imaging performed during cervical traction.

Previous SectionNext Section

© RSNA, 2002

Cervical traction has been applied widely to relieve neck pain from muscle spasm or nerve compression in rehabilitation medicine settings (1,2). Continuous or intermittent traction has been regarded as an effective treatment for herniated cervical disks (HCDs) because it facilitates widening of the disk spaces (3,4). The traction induces pain relief and regression of the herniated disks. Several reports (5–7) have described the regression of herniated disks either spontaneously or within the treatment period.

Widening of disk space during traction has been demonstrated mostly on radiographs (1). Radiography does not yield direct images of the herniated disk, however; radiographs show only the changes in vertebral bone structures. Direct visualization of the cervical disk would be very helpful for evaluating the reducibility of disk herniation during traction, and magnetic resonance (MR) imaging is the best examination for evaluation of intervertebral disk problems. To our knowledge, however, a device that enables visualization of the cervical disk during traction and is applicable to MR imaging has not been available before now. Although a portable traction device for cervical fractures has been reported on, the report was in the form of a technical note regarding a portable traction device that can be used with myelography or computed tomography (CT) (8). The study was not applicable to MR imaging because the metallic composition of the described traction device produced substantial artifacts.

We have designed a portable intermittent traction device made of nonmagnetic materials that do not affect MR imaging. The purpose of our study was to evaluate the reducibility of cervical disk herniation at MR imaging performed with the patient in cervical traction.

Previous SectionNext Section

Materials and Methods

For 19 months, from June 1999 to November 2000, a total of 29 patients who consecutively received a diagnosis of HCD on the basis of findings at previously performed cervical CT or MR imaging and seven healthy volunteers were examined at cervical spinal MR imaging. The healthy volunteers were selected from a group of young persons during two stages: First, a rehabilitation physician (S.W.K.) selected young (ie, aged 18–40 years) healthy volunteers if they had none of the following symptoms or signs: pain, stiffness, tenderness, fracture, dislocation, neurologic signs such as decreased or absent deep tendon reflexes, weakness, sensory deficits, or muscular signs such as decreased range of motion or point tenderness. Next, the selected volunteers underwent T2-weighted MR imaging while in a neutral (ie, nontraction) state, and if either a degenerative change in or a herniation of a disk was detected, the subject was excluded. Finally, the selected volunteers underwent MR imaging while wearing the inflated traction device.

The patient group consisted of 10 men and 19 women, who ranged in age from 25 to 62 years (mean age, 44.4 years). The healthy volunteer group consisted of one man and six women, who ranged in age from 19 to 37 years (mean age, 26 years). The MR imaging examinations were performed after informed consent had been obtained from all patients and volunteers, as was required by the institutional review board of Yonsei University College of Medicine, YongDong Severance Hospital.

Traction Device

The traction device (Fig 1) was originally designed for portable intermittent use to accommodate a patient’s daily activities during traction. It is also constructed of a nonmagnetic material (Airtrac 101; Airtrac MSI, Seoul, Korea) that is compatible to MR imaging units. The traction device consists of three main parts: (a) a shoulder cover for the base of the device, (b) an accordion-shaped middle component that can be expanded by means of air inflation, and (c) mandible supports for effective transmission of traction. When the device is inflated with air, the accordion-shaped middle component stretches and has a traction effect on the neck. The anterior portion of the middle component is fixed with a band to maintain a flexion posture of the neck. We used 30 pounds of traction force: The pressure to the internal space was 0.4 kgf/cm². Immediately after the procedure, we asked the volunteers and patients if they had experienced any pain or other discomfort during inflation of the traction device or during imaging.

View larger version:

• In this page
• In a new window

• Download as PowerPoint Slide

Figure 1a. Cervical traction device used on a healthy volunteer. (a, b) The traction device consists of a shoulder cover at the base of the device (1), an accordion-shaped middle component that is expanded by means of air inflation (2), and mandible supports for effective transmission of traction (3). In b, the anterior portion (4) of the middle component is fixed with a band to maintain a flexion posture of the neck. (c, d) When the device is inflated with air, the accordion-shaped middle component stretches to have a traction effect on the neck.

View larger version:

• In this page
• In a new window

• Download as PowerPoint Slide

Figure 1b. Cervical traction device used on a healthy volunteer. (a, b) The traction device consists of a shoulder cover at the base of the device (1), an accordion-shaped middle component that is expanded by means of air inflation (2), and mandible supports for effective transmission of traction (3). In b, the anterior portion (4) of the middle component is fixed with a band to maintain a flexion posture of the neck. (c, d) When the device is inflated with air, the accordion-shaped middle component stretches to have a traction effect on the neck.

View larger version:

• In this page
• In a new window

• Download as PowerPoint Slide

Figure 1c. Cervical traction device used on a healthy volunteer. (a, b) The traction device consists of a shoulder cover at the base of the device (1), an accordion-shaped middle component that is expanded by means of air inflation (2), and mandible supports for effective transmission of traction (3). In b, the anterior portion (4) of the middle component is fixed with a band to maintain a flexion posture of the neck. (c, d) When the device is inflated with air, the accordion-shaped middle component stretches to have a traction effect on the neck.

View larger version:

• In this page
• In a new window

• Download as PowerPoint Slide

Figure 1d. Cervical traction device used on a healthy volunteer. (a, b) The traction device consists of a shoulder cover at the base of the device (1), an accordion-shaped middle component that is expanded by means of air inflation (2), and mandible supports for effective transmission of traction (3). In b, the anterior portion (4) of the middle component is fixed with a band to maintain a flexion posture of the neck. (c, d) When the device is inflated with air, the accordion-shaped middle component stretches to have a traction effect on the neck.

MR Imaging

All MR imaging studies were performed by using a 1.5-T MR system (Vision; Siemens, Erlangen, Germany) with 25-mT/m gradient capability. With the patient wearing the traction device, standard cervical spinal MR images were acquired with sagittal turbo spin-echo T2-weighted and transverse two-dimensional fast low-angle shot sequences by using a standard spine circular polarization array coil. The parameters for sagittal turbo spin-echo T2-weighted MR imaging were 4,000/128 (repetition time msec/echo time msec), a 138 × 256 matrix, a 156 × 250-mm field of view, and nine images of 3-mm section thickness obtained during an acquisition time of 52 seconds. The parameters for transverse two-dimensional fast low-angle shot MR imaging were 550/12, a 30° flip angle, a 112 × 256 matrix, a 125 × 200-mm field of view, and nine images of 3-mm section thickness obtained during an acquisition time of 2 minutes 5 seconds. We reduced the matrix number to less than that used to obtain standard MR images, to minimize the acquisition time and motion artifacts.

First, neutral-state images were obtained during deflation of the traction device. Then, traction-state images were obtained 10 minutes after inflation with an external air tube to allow time for the traction effect on the normal or herniated disk. The patients and volunteers were monitored with closed-circuit television surveillance and could communicate by means of microphone to prevent unexpected emergency situations during traction.

Image Analysis

As a parameter of cervical vertebral column elongation, the distance between the middle point of the superior border of the C1 anterior arch and the inferoposterior point of the C7 vertebral body on magnified sagittal MR images was measured by using the computer console of the MR imaging unit (Vision). We did not use the odontoid process as the superior landmark because exact localization of the odontoid process tip could have been difficult sometimes owing to a patient’s tilting or rapid position change during traction. Measurements of cervical vertebral column elongation were obtained by two neuroradiologists (T.S.C., Y.J.L.) separately and blindly. The neuroradiologists were not informed of the patients’ clinical information.

The reducibility of cervical disk herniation was evaluated in the patient group. Complete resolution of the herniation was defined as a result in which the disk was completely inside the annulus margin without a residual herniated disk particle. Partial reduction was defined as a more than 50% volume reduction in the herniated disk particle with some residual tissue. The reduction ratio was calculated as follows: [(D − d)/D] × 100, where D is the distance between two parallel lines—one line drawn at the base of the herniated disk particle and the other drawn at the tip—in the neutral state and d is this distance in the traction state (Fig 2).

View larger version:

• In this page
• In a new window

• Download as PowerPoint Slide

Figure 2. Measurement of reduction ratio. Reduction ratio was calculated as follows: [(D − d)/D] × 100. D is the distance between two parallel lines—one line drawn at the base of the herniated disk particle and the other drawn at the tip—in the neutral state, and d is this distance in the traction state.

Whether there was widening of the facet joints or intervertebral foramen during traction was determined in the patients and healthy volunteers. Retraction of the posterior margin of the disk during traction, as depicted on sagittal MR images, also was evaluated in the volunteers and patients. If the retracted posterior margin of the disk passed an imaginary line drawn from the posterior margins of two adjacent vertebral bodies, we defined this phenomenon as dimpling.

The two radiologists evaluated the pre- and post traction images side by side, without knowledge of the patients’ clinical information. The radiologists reviewed the images simultaneously, and results were recorded when they reached a consensus.

Statistical Analysis

The extent of cervical vertebral column elongation in the patients during traction was compared with that in the healthy volunteers. Statistical analysis was performed by using computer software (SPSS; SPSS, Chicago, Ill and Excel 2000; Microsoft Korea, Seoul, Korea). The Mann-Whitney U test was used to analyze our study data, and a P value of less than .05 was considered to indicate a statistically significant difference.

Previous SectionNext Section

Results

The MR images obtained in the seven healthy volunteers during traction showed that the length of the cervical vertebral column had increased by 0–3 mm (mean length increase, 1.93 mm). Of the 29 patients, 21 (72%) had complete resolution or partial reduction of the cervical disk herniation and an elongation of the cervical vertebral column of 0–7 mm (mean length increase, 2.19 mm), which was not significantly different from that in the volunteers (P = .917). Eight patients had minimal elongation of the cervical vertebral column (mean length increase, 0.44 mm), which was significantly shorter than that in the healthy volunteers (P < .001) (Table 1). No patient reported having pain or any other discomfort during either traction device inflation or MR imaging.

View this table:

• In this window
• In a new window

TABLE 1. Increased Length of Cervical Vertebral Column during Traction

Of the 29 patients, who had a total of 40 HCDs, 19 had an HCD at one cervical disk level, nine had HCDs at two levels, and one had HCDs at three levels. There were 15 HCDs each at the C5–6 and C6-7 cervical disk levels. There were five HCDs at the C3-4 level, three at the C4-5 level, and two at the C7-T1 level. In the patient with HCDs at three levels, the herniation at one level was reduced but the herniations at the two remaining levels were not. In the nine patients with HCDs at two levels (total of 18 levels), the herniations were reduced at 13 levels and not reduced at five levels. Of the 19 patients with HCDs at one level, 13 had reduced herniations and six did not.

Disk herniation was completely resolved in three (10%) of the 29 patients (Fig 3) and partially reduced in 18 (62%) (Fig 4). Eight of the 29 patients had minimal elongation of the cervical vertebral column during traction (mean length increase, 0.44 mm; range, 0–1.5 mm), however, and no reduction of the disk herniation. The length of elongation of the cervical vertebral column during traction in this group was significantly shorter than that in the healthy volunteers (P = .02). There was a significant difference in elongation of the vertebral column between the patients who did and those who did not have some herniation reduction (P = .01).

View larger version:

• In this page
• In a new window

• Download as PowerPoint Slide

Figure 3a.(a, b) Sagittal (4,000/128) and (c, d) transverse (two-dimensional fast low-angle shot sequence, 550/12, 30° flip angle) MR images depict a completely resolved cervical disk herniation after traction. (a, c) Neutral-state MR images show extrinsic compression of the dural sac and spinal cord at the C5-6 cervical disk level due to an HCD (arrow). (b, d) Traction-state MR images show reduction of the cervical disk herniation and the residual deformed spinal cord. Widening of the right-side facet joint space (arrow in d) is seen on the transverse traction-state image.

View larger version:

• In this page
• In a new window

• Download as PowerPoint Slide

Figure 3b.(a, b) Sagittal (4,000/128) and (c, d) transverse (two-dimensional fast low-angle shot sequence, 550/12, 30° flip angle) MR images depict a completely resolved cervical disk herniation after traction. (a, c) Neutral-state MR images show extrinsic compression of the dural sac and spinal cord at the C5-6 cervical disk level due to an HCD (arrow). (b, d) Traction-state MR images show reduction of the cervical disk herniation and the residual deformed spinal cord. Widening of the right-side facet joint space (arrow in d) is seen on the transverse traction-state image.

View larger version:

• In this page
• In a new window

• Download as PowerPoint Slide

Figure 3c.(a, b) Sagittal (4,000/128) and (c, d) transverse (two-dimensional fast low-angle shot sequence, 550/12, 30° flip angle) MR images depict a completely resolved cervical disk herniation after traction. (a, c) Neutral-state MR images show extrinsic compression of the dural sac and spinal cord at the C5-6 cervical disk level due to an HCD (arrow). (b, d) Traction-state MR images show reduction of the cervical disk herniation and the residual deformed spinal cord. Widening of the right-side facet joint space (arrow in d) is seen on the transverse traction-state image.

View larger version:

• In this page
• In a new window

• Download as PowerPoint Slide

Figure 3d.(a, b) Sagittal (4,000/128) and (c, d) transverse (two-dimensional fast low-angle shot sequence, 550/12, 30° flip angle) MR images depict a completely resolved cervical disk herniation after traction. (a, c) Neutral-state MR images show extrinsic compression of the dural sac and spinal cord at the C5-6 cervical disk level due to an HCD (arrow). (b, d) Traction-state MR images show reduction of the cervical disk herniation and the residual deformed spinal cord. Widening of the right-side facet joint space (arrow in d) is seen on the transverse traction-state image.

View larger version:

• In this page
• In a new window

• Download as PowerPoint Slide

Figure 4a.(a, b) Sagittal (4,000/128) and (c, d) transverse (two-dimensional fast low-angle shot sequence, 550/12, 30° flip angle) MR images of a partially reduced cervical disk herniation after traction. (a, c) Neutral-state MR images show a small area of high signal intensity (arrow) that corresponds to a herniated disk fragment in the posterior central direction at the C5-6 cervical disk level. (b, d) Traction-state MR images show a reduction of the fragment (arrow in b) through a torn tract of the annulus fibrosus at the C5-6 cervical disk level.

View larger version:

• In this page
• In a new window

• Download as PowerPoint Slide

Figure 4b.(a, b) Sagittal (4,000/128) and (c, d) transverse (two-dimensional fast low-angle shot sequence, 550/12, 30° flip angle) MR images of a partially reduced cervical disk herniation after traction. (a, c) Neutral-state MR images show a small area of high signal intensity (arrow) that corresponds to a herniated disk fragment in the posterior central direction at the C5-6 cervical disk level. (b, d) Traction-state MR images show a reduction of the fragment (arrow in b) through a torn tract of the annulus fibrosus at the C5-6 cervical disk level.

View larger version:

• In this page
• In a new window

• Download as PowerPoint Slide

Figure 4c.(a, b) Sagittal (4,000/128) and (c, d) transverse (two-dimensional fast low-angle shot sequence, 550/12, 30° flip angle) MR images of a partially reduced cervical disk herniation after traction. (a, c) Neutral-state MR images show a small area of high signal intensity (arrow) that corresponds to a herniated disk fragment in the posterior central direction at the C5-6 cervical disk level. (b, d) Traction-state MR images show a reduction of the fragment (arrow in b) through a torn tract of the annulus fibrosus at the C5-6 cervical disk level.

View larger version:

• In this page
• In a new window

• Download as PowerPoint Slide

Figure 4d.(a, b) Sagittal (4,000/128) and (c, d) transverse (two-dimensional fast low-angle shot sequence, 550/12, 30° flip angle) MR images of a partially reduced cervical disk herniation after traction. (a, c) Neutral-state MR images show a small area of high signal intensity (arrow) that corresponds to a herniated disk fragment in the posterior central direction at the C5-6 cervical disk level. (b, d) Traction-state MR images show a reduction of the fragment (arrow in b) through a torn tract of the annulus fibrosus at the C5-6 cervical disk level.

Widening of the facet joint space was observed at MR imaging during traction in two (29%) of the seven healthy volunteers and in five (17%) of the 29 patients (Fig 5). In addition, foraminal widening was observed in one (14%) of the seven volunteers and in five (17%) of the 29 patients. Dimpling of the annulus capsule due to the secondary retraction effect of the increased disk length was observed on the sagittal MR images obtained in three (43%) of the seven healthy volunteers and in 12 (41%) of the 29 patients (Fig 6) (Table 2).

View this table:

• In this window
• In a new window

TABLE 2. Dimpling of Annulus Capsules and Changes in Facet Joints and Intervertebral Foramina during Traction

View larger version:

• In this page
• In a new window

• Download as PowerPoint Slide

Figure 5. Sagittal T2-weighted MR images (4,000/128) of the foramen at the C6-7 cervical disk level and the facet joint at the C7-T1 cervical disk level in a patient with HCD in (a) neutral and (b) traction states. The facet joint (arrow) is widened at traction (b) compared with in the neutral state (a). The width of the foramen (arrowheads) also increased with traction.

View larger version:

• In this page
• In a new window

• Download as PowerPoint Slide

Figure 6a. Sagittal T2-weighted MR images (4,000/128) of the cervical spine of a healthy volunteer in (a) neutral and (b) traction states. Dimpling of the annulus capsule (arrow in b) is seen at traction.

View larger version:

• In this page
• In a new window

• Download as PowerPoint Slide

Figure 6b. Sagittal T2-weighted MR images (4,000/128) of the cervical spine of a healthy volunteer in (a) neutral and (b) traction states. Dimpling of the annulus capsule (arrow in b) is seen at traction.

Previous SectionNext Section

Discussion

Although regression of a herniated intervertebral disk at follow-up has been reported in up to 3% of cases of herniated cervical or lumbar disks (6,7), the exact mechanism of the regression of a herniated intervertebral disk is still not understood. The disk may be subject to desiccation and shrinkage from loss of hydrophilic proteoglycans, which leads to a loss of water content and, consequently, a decrease in disk size (7). Reports (8,9) have suggested that traction therapy can induce HCD regression. However, the mechanism of the disappearance of the HCD at follow-up MR imaging after traction—that is, whether it is a reduction or a spontaneous resorption—is still unclear.

In a report (1), it is stated that the length of a cervical disk increases during traction. The report only describes those changes in disk length that were identified by measuring the distance between the bone margins of adjacent vertebral bodies on radiographs, however. Therefore, the reduction of a herniated disk particle during traction could not be precisely evaluated in that study.

If cervical spinal MR imaging could be performed simultaneously with traction, the changes in intervertebral disks could be directly evaluated. A cervical traction device for MR imaging should be made of nonmagnetic materials. In addition, the volume of the device should be small enough to fit easily on the limited space of an MR gantry and coil while inducing an adequate traction force. Therefore, we designed a device that can be expanded by means of air inflation. With expansion of the device, elongation of the neck between the shoulder and the occiput can be achieved. The device has a traction effect on the cervical vertebral column that is similar to that of conventional traction methods that are applied at bedside. We used 30 pounds of traction force (ie, pressure to the internal space of 0.4 kgf/cm²) because early separation of the posterior vertebral segment is induced by applying a minimum pressure of 25 pounds (10).

In our evaluation of the changes in HCDs during traction at MR imaging, we observed a reduced herniated nucleus pulposus particle through the tract of a torn annulus (Fig 4). This suggests that direct reduction effects on HCDs can be verified at MR imaging performed during traction. Although long-term follow-up was not performed in this study, we believe that reduction of the herniated nucleus pulposus might lead to healing of the torn annulus and resolution of the disk herniation. Complete resolution or partial reduction of a disk herniation was seen in 21 patients; these results suggest that traction has an effect on HCDs.

All seven healthy volunteers and 21 (72%) of the 29 patients with HCD showed substantial elongation of the cervical vertebral column after the traction device was applied and inflated.

In a cadaveric study (11), there were significant increases in the intervertebral foraminal volume and the size of the area at the foraminal isthmus. We also induced a flexion posture of the cervical spine during traction. However, neither widening of the facet joint space (in two [29%] volunteers and five [17%] patients) nor widening of the intervertebral foramen (in one [14%] volunteer and five [17%] patients) was frequent. These results might have been due to the thickness of sections on sagittal images, which may have been such that very rapid changes in the facet joint and intervertebral foramen could not be sufficiently evaluated.

Dimpling of the annulus capsule of the cervical disk was seen in three (43%) of the seven volunteers and in 12 (57%) of the 21 patients who had elongation of the cervical vertebral column during traction. This dimpling might have been a secondary effect of cervical vertebral column traction and may represent a response to the traction. Responding to the traction, intervertebral disks can show dimpling of the annulus capsule by increasing the length of disk space, which instantly results in negative pressure on the disk. Owing to its flexibility, the disk decreases in width to resolve this phenomenon. However, a disk that does not respond to the traction might not show dimpling of the annulus capsule.

In conclusion, cervical spinal MR imaging performed during cervical traction with a portable intermittent traction device can be used to evaluate the reducibility of cervical disk herniation with traction.

Previous SectionNext Section

Previous SectionNext Section

Acknowledgments

The authors thank Yong-Jae Lee, MD, for advice and support and for serving as a photographic model in the volunteer study.

Previous SectionNext Section

Footnotes

• Abbreviation: HCD = herniated cervical disk
• Author contributions: Guarantor of integrity of entire study, T.S.C.; study concepts, T.S.C.; study design, T.S.C., C.J.P.; literature research, T.S.C., S.W.K.; clinical studies, T.S.C., Y.J.L., S.W.K., C.J.P.; experimental studies, T.S.C., C.J.P., Y.W.S.; data acquisition, T.S.C., W.S.K.; data analysis/interpretation, Y.W.S., T.S.C., Y.J.L.; statistical analysis, W.S.K.; manuscript preparation, T.S.C., Y.J.L.; manuscript definition of intellectual content, Y.J.L.; manuscript editing, Y.W.S., T.S.C., Y.J.L.; manuscript revision/review, T.S.C., Y.J.L., W.S.K.; manuscript final version approval, T.S.C.

Index terms: Magnetic resonance (MR), functional imaging, 316.12144 Spine, intervertebral disks Spine, MR, 316.121411, 316.121412, 316.12144

Previous Section

References

1. ↵
   Wong AMK, Leong CP, Chen CM. The traction angle and cervical intervertebral separation. Spine 1992; 18:136-138.
2. ↵
   Saunders HD. Use of spinal traction in the treatment of neck and back conditions. Clin Orthop 1983; 179:31-38.
3. ↵
   Rendina APM, Benazzo F, Castelli C, Paparella F. The statics of cervical traction. J Spinal Disord 1994; 7:337-343.

   Medline
4. ↵
   Valtonen EJ, Moller K, Wiljasalo M. Comparative radiographic study of the effect of intermittent and continuous traction on elongation of cervical spine. Ann Med Intern Finn 1968; 57:143-146.
5. ↵
   Bozzao A, Galluci M, Masciocchi C, Aprile I, Barile A, Passariello R. Lumbar disk herniation: MR imaging assessment of natural history in patients with treated without surgery. Radiology 1992; 185:135-141.

   Abstract/FREE Full Text
6. ↵
   Teplick JG, Haskin ME. Spontaneous regression of herniated nucleus pulposus. AJNR Am J Neuroradiol 1985; 6:331-335.
7. ↵
   BenEliyahu DJ. Magnetic resonance imaging and clinical follow-up: study of 27 patients receiving chiropractic care for cervical and lumbar disc herniation. J Manipulative Physiol Ther 1996; 19:597-606.

   Medline
8. ↵
   Kinnaird RH, Jelsma R. A portable traction device for cervical fractures. J Neurosurg 1992; 76:544-545.

   Medline
9. ↵
   Saal JS, Saal JA, Yurth EF. Nonoperative management of herniated cervical intervertebral disc with radiculopathy. Spine 1996; 21:1877-1883.

   CrossRefMedline
10. ↵
    Judovich BD. Herniated cervical disc: a new form of traction therapy. Am J Surg 1952; 84:646-656.

    CrossRefMedline
11. ↵
    Humphreys SC, Chase J, Patwardhan A, Shuster J, Lomasney L, Hodges SD. Flexion and traction effect on C5-C6 foraminal space. Arch Phys Med Rehabil 1998; 79:1105-1109.

    CrossRefMedline

Americans Are Over Medicated

 

The Drugging Of Americans and Medical Industry Greed 

Is America over medicated? 

Is the FDA more interested in Americans'  health, safety, & well being or the billions of dollars it receives annually from the pharmaceutical companies to approve new drugs & keep current drugs on the market? 

 Please read the following list of disturbing facts & statistics & decide for yourself.

• Based on a 2002 survey, 46% of Americans use at least one prescription drug daily.
• Total number of prescriptions filled in 2001:  3.1 billion
• Total cost of prescriptions in 2001: $132 billion
• Projected cost of prescriptions in 2014: $414 billion
• Percentage of incoming undergraduates using psychotropic, mind-altering drugs:  40%
• From 1992 - 2003, the abuse of psychotropic drugs grew at twice the rate of marijuana abuse; five times that of cocaine abuse; & 60 times that of heroin abuse.
• 20% of recently approved prescription drugs have serious, life threatening side effects. 
• 90% of authors of clinical practice guidelines received research funding from, or acted as consultants to drug companies. 
• Medical doctors, psychiatrists, & all those licensed by the government who can "legally" prescribe drugs are paid huge monetary incentives by the pharmaceutical industry to write prescriptions of their drugs. Those doctors & other professionals who choose financial incentives over a patients well being & health should be defined as "legal drug pushers" contributing to the overmedicating of America for profit.
• Percentage increase from 1985 - 1999 in stimulant psychotropic drugs prescribed to children: 327%
• Percentage increase from 1991 - 2000 in stimulant psychotropic drugs prescribed to preschoolers between 2 & 4 years of age: 50%
• The number of antidepressants prescribed annually for children under 19: 11 million 
• The number of children diagnosed with "ADD/ADHD" & drugged in 1985: 500,000
• The number of children diagnosed with "ADD/ADHD" & drugged today: approximately 6 million
• CHADD (Children and Adults with ADD) received over $700,000 in 2001 from pharmaceutical companies to promote & market their drugs.
• CHADD refers to the 1999 Surgeon General's Report on Mental Health when citing ADHD as a neurobiological disorder, yet the Surgeon General's report, the DSM-IV, the National Institutes of Health, and the American Academy of Pediatrics Clinical Practice Guideline for ADHD, do not confirm or state that ADHD is a "neurobiological" disorder. In fact, the Surgeon General provided no conclusive evidence to support this theory—a fact CHADD neglects to mention on its website.
• The epidemic use of psychotropic drugs started many years ago. In 1965, approximately 58 million new prescriptions & 108 million refills were written for psychotropic drugs. This accounted for 14% of all prescriptions written that year.
• Percentage of Americans taking anti-allergy medications who may not even have allergies: 65%
• The number of signs advertising the drug Claritin in Newark International Airport lobbies:  75
• The amount spent by Merck Pharmaceutical to advertise the drug Vioxx in 2001:  $161 million
• The total number of advertising violations issued by the FDA for misleading drug ads from 1997 - 2001:  88; Amount of fines levied for such violations: $0
• US direct-to-consumer drug ad spending soared to $2.49 billion in 2001 up from $859 million in 1997.
• Number of Americans annually who request & receive a prescription for a specific drug after seeing a commercial for it: 8.5 million
• Estimated prescriptions of Paxil in 2002: 37 million
• Amount spent on lobbying by pharmaceutical companies from 1996 - 2002: $500 million
• The number of former congressmen now serving as lobbyists for the pharmaceutical industry: 24
• The approximate total number of lobbyists: 600; Their average annual income: $300,000 - $400,000
• The amount of direct contributions from the drug industry to the 2002 political campaign: $20 million; Percentage that went to Republicans: 75%
• Seven drugs recalled by the FDA between 1993 & 2000 after reports of death & severe side effects exceeded $5 billion in sales before being withdrawn.
• The major stockholders of the pharmaceutical industry: FDA workers, FTC workers, Congressmen, & the CEO's of the pharmaceutical companies.
• The Annual cost of prescription drug errors: $100 billion
• A natural herbal cure was found for diabetes. The amount paid to the person that discovered it to not market or announce the cure: $30 million
• Out of the last 20 FDA commissioners, upon leaving the FDA, the number who went to work directly for the pharmaceutical industry: 12
• The approximate number of Americans that die annually from FDA approved drugs: 125,000
• The approximate number of Americans that die annually from Aspirin use: 2,000
• The percentage of FDA workers who are paid directly through funding from the pharmaceutical industry:  55% at an average of $1.2 billion annually
• The FDA passed a law stating that only a "drug" can cure a disease therefore; farms, orchards, or any company promoting fruit as beneficial to your health were threatened with violations & the confiscation & destruction of their products. Their "cherries" for example were not approved as a new drug by the FDA & were not declared as "safe & effective". The average cost to get a "new drug" approved: $800 million.  Sound unbelievable? Actual FDA letter sent to a farm marketing cherries as a natural remedy.
• In 2004 approximately 12,000 Texas Foster Children each received 21 prescriptions of psychotropic drugs totally more than $29 million.
• According to a recent study, up to 20% of all prescriptions written are for "off-label" use not approved by the FDA & with no support from scientific studies.
• According to a recent study, 96% of all "off-label" psychiatric drug prescriptions lacked scientific support.
• 25% of 239 patients consuming Vioxx had heart attacks within the first 13 days of  being on the drug. Vioxx was pulled from the market on September 30th, 2004. 
• The amount of money the pharmaceutical industry & the FDA would loose if Americans turned to natural cures (vitamins, minerals, herbs, fruit, etc.) instead of prescription drugs: trillions!

    


                                                                Visit CHAADA on Myspace!                                           
Disclaimer:  The information posted on this website is for educational purposes only. We are not licensed Medical Doctors & do not intend to substitute the advice of professionals. The information presented is based on our opinions on the benefits of alternative treatment vs. drugging for treatment. Some of our sources include websites of licensed Medical Doctors & websites of others sharing our opinions. Any mention on this site of alternative treatment & healing through natural remedies, organic or herbal, have not been evaluated by the FDA. Again, some  information on this site is based solely on personal experiences & personal opinions & is protected under Free Speech.

Former Bain Capital Partner Edward Conard Outs Romney

A former Bain Capital partner acknowledged Sunday that Mitt Romney "legally" remained the head of the private equity firm until 2002, contradicting Romney's claims that he left the company in February 1999.

During an appearance on MSNBC's "Up w/ Chris Hayes," Edward Conard, who worked at the private equity firm during Romney's tenure as CEO, noted that Romney remained "legally" in charge of the company for at least two years after the former governor says he left to take over the Olympic Games in Salt Lake City.

"Mitt's names were on the documents as the chief executive and sole owner of the company," Conard said. Conard served as managing director of the firm from 1993 to 2007.



MSNBC reports:

Despite Romney's statements that he left in 1999, Conard's new remarks suggest that, in fact, Romney's continued ownership of the firm enabled him to negotiate a better exit deal. "We had to negotiate with Mitt because he was an owner of the firm," Conard said.The legal transfer of ownership dragged on for three years after Romney's informal departure to run the Olympics in Salt Lake City, Conard said, because Romney was aggressively negotiating his retirement package and compensation with executives and lawyers at the company.

"He'd created a lot of franchise value, and we were going to pay him for that," Conard said, adding: "We had a very complicated set of negotiations that took us about two years for us to unwind. During that time a management committee ran the firm, and we could hardly get Mitt to come back to negotiate the terms of his departure because he was working so hard on the Olympics."

Conard's comments are the latest in a growing pile of evidence that contradicts Romney's repeated claims that he ended his active role at Bain in 1999. On Sunday, The Huffington Post reported on a corporate document filed in December 2002 that lists Romney as a "managing member" of Bain Capital Investors. Earlier reports show Romney listed as CEO on 2002 Securites and Exchange Commission filings, attending board meetings for Bain-affiliated companies after 1999, and receiving an at least $100,000 salary from Bain in 2001 and 2002.

The discrepancies between these documents and Romney's account of his departure have become the focus of the presidential campaign, as President Obama's team raises questions about the Republican candidate's truthfulness. Beyond the issue of honesty, there are deeper implications for Romney if he was involved in the company after 1999, as Bain's outsourcing activity during that time has raised concern.

Obama addressed the controversy on Saturday, telling DC-based ABC affiliate WJLA that Romney should come clean on his record.

"Ultimately, I think, Mr. Romney is going to have to answer those questions because if he aspires to being president, one of the things you learn is you're ultimately responsible for the conduct of your operations," the president said.

Obamacare Will Cut Deficit...

CBO: Health reform to cut deficit by $50 billion more than we thought... Republicans lie about health care. See them get busted.

http://www.washingto...gPSES_blog.html

I’m getting a lot of e-mails quoting articles like this one, by John Ransom, that say something like, “In a wholly predictable development, it turns out the cost for Obamacare will end up being twice the original price that the Democrats said.” Ransom also writes that I was “w-w-w-wrong” to say, back in January 2011, that the law “cuts enough spending and raises enough taxes to more than pay for itself.”

Actually, no, I wasn’t. That statement, in fact, is even truer today than it was then.

But let’s back up. The occasion for this dust-up is a set of updated cost estimates for the coverage provisions of the health-care law. The new estimates reflect a couple of factors. The Congressional Budget Office lists them:

- An increase of $168 billion in projected outlays for Medicaid and CHIP;

- A decrease of $97 billion in projected costs for exchange subsidies and related spending;

- A decrease of $20 billion in the cost of tax credits for small employers; and

- An additional $99 billion in net deficit reductions from penalty payments, the excise tax on high-premium insurance plans, and other effects on tax revenues and outlays—with most of those effects reflecting changes in revenues.

You’ll notice something about the above list: It appears to add up to a net reduction in the cost of the health-care law. And, sure enough, here’s CBO: “the insurance coverage provisions of the ACA will have a net cost of just under $1.1 trillion over the 2012–2021 period—about $50 billion less than the agencies’ March 2011 estimate.” You would get the opposite impression reading Ransom.

The problem for Ransom and others is that they didn’t read this analysis closely, or, if they did, they didn’t understand it.

Ransom quotes CBO saying “those provisions will increase deficits by $1,083 billion,” but he either didn’t notice or didn’t choose to include the CBO’s warning that this analysis does “not encompass all of the budgetary impacts of the ACA because that legislation has many other provisions, including some that will cause significant reductions in Medicare spending and others that will generate added tax revenues.”

As it says right in the title, this is just a look at “the insurance coverage provisions” of the Affordable Care Act. That is to say, it’s a look at the spending side of the bill. So it doesn’t include the Medicare cuts, or many of the tax increases, that pay for the legislation. It’s like reading only the “outlays” side of the budget and ignoring the “revenues” part. Of course that would make the deficit look huge.

But those other parts of the bill aren’t a secret. They’re mentioned right there in the analysis. Quoting again: “CBO and JCT have previously estimated that the ACA will, on net, reduce budget deficits over the 2012–2021 period; that estimate of the overall budgetary impact of the ACA has not been updated.”

It’s easy to do at least some of the update ourselves. This analysis shows the net cost of the coverage provisions will be about $50 billion less than previously estimated. That implies the law will cut more, not less, from the deficit than previous estimates suggested. In other words, this estimate says the bill is more, not less, fiscally responsible than was previously reported.

One other thing that’s confused some people is that this estimate is looking at a different timeframe than the original estimates. The CBO’s first pass at the bill looked at 2010-2019. But years have passed, and so now they’re looking at 2012-2021. That means they have two fewer years of implementation, when the bill costs almost nothing, and two more years of operation, when it costs substantially more.

But it also means that the included cuts and taxes, which grow with time, are larger. That’s why, when House Republicans wanted to repeal health reform in 2011, the estimated increase in the deficit was $230 billion, rather than the $130 billion that would have been expected from the 2010-2019 analysis. As you extend the analysis, the bill both costs more and saves more, and the savings grow more quickly than the costs.

There are a few other interesting things in the CBO report: It says, for instance, that the bill is now expected to cover 30 million Americans, rather than 33 million Americans. It doesn’t give a reason for the revision.

Glenn Beck On Health Care Reform

A Compliation of FDA Corruption

http://www.youtube.com/watch?v=gBeXPYah6yw

http://www.youtube.com/watch?v=B6eGQDuU88E&feature=related

Hear Doctor/Congressman Ron Paul Explain It!

Shocking Facts About FDA Corruption